                               SEQUENCE LISTING

<110> OPHTHOTECH CORPORATION
 
<120> A METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL
      CHOROIDAL VASCULOPATHY (IPCV)

<130> A112.37

<140>
<141>

<160> 1     

<170> PatentIn version 3.5

<210> 1
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220>
<223> Description of Combined DNA/RNA Molecule: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (1)..(1) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (2)..(2) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (3)..(4) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (6)..(6) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (7)..(8) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (9)..(12) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (13)..(15) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (16)..(16) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (18)..(19) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (20)..(22) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (23)..(25) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (26)..(28) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (29)..(31) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (33)..(35) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (36)..(36) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (37)..(37) 
<223> 2'-fluoro nucleotide

<220>
<221> modified_base
<222> (38)..(38) 
<223> 2'-OMe nucleotide

<220>
<221> modified_base
<222> (39)..(39) 
<223> Inverted deoxy thymidine

<400> 1
cgccgcgguc ucaggcgcug agucugaguu uaccugcgt                              39


